BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 30600369)

  • 1. Blood Lactate as a Reliable Marker for Mortality of Pediatric Refractory Cardiogenic Shock Requiring Extracorporeal Membrane Oxygenation.
    Yang L; Fan Y; Lin R; He W
    Pediatr Cardiol; 2019 Mar; 40(3):602-609. PubMed ID: 30600369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactate and lactate clearance as valuable tool to evaluate ECMO therapy in cardiogenic shock.
    Slottosch I; Liakopoulos O; Kuhn E; Scherner M; Deppe AC; Sabashnikov A; Mader N; Choi YH; Wippermann J; Wahlers T
    J Crit Care; 2017 Dec; 42():35-41. PubMed ID: 28672145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes following venoarterial extracorporeal membrane oxygenation in children with refractory cardiogenic disease.
    Yang L; Ye L; Fan Y; He W; Zong Q; Zhao W; Lin R
    Eur J Pediatr; 2019 Jun; 178(6):783-793. PubMed ID: 30834480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early dynamic behavior of lactate is linked to mortality in postcardiotomy patients with extracorporeal membrane oxygenation support: A retrospective observational study.
    Li CL; Wang H; Jia M; Ma N; Meng X; Hou XT
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1445-50. PubMed ID: 25534305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between serum lactate levels and mortality in patients with cardiogenic shock receiving mechanical circulatory support: a multicenter retrospective cohort study.
    Scolari FL; Schneider D; Fogazzi DV; Gus M; Rover MM; Bonatto MG; de Araújo GN; Zimerman A; Sganzerla D; Goldraich LA; Teixeira C; Friedman G; Polanczyk CA; Rohde LE; Rosa RG; Wainstein RV
    BMC Cardiovasc Disord; 2020 Nov; 20(1):496. PubMed ID: 33234107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does lactate clearance prognosticates outcomes in ECMO therapy: a retrospective observational study.
    Mungan İ; Kazancı D; Bektaş Ş; Ademoglu D; Turan S
    BMC Anesthesiol; 2018 Oct; 18(1):152. PubMed ID: 30355289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality].
    Loforte A; Pilato E; Martin Suarez S; Folesani G; Jafrancesco G; Castrovinci S; Cefarelli M; Potena L; Magnani G; Grigioni F; Caramelli F; Frascaroli G; Di Bartolomeo R; Marinelli G
    G Ital Cardiol (Rome); 2014 Oct; 15(10):577-85. PubMed ID: 25424022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors.
    Loforte A; Marinelli G; Musumeci F; Folesani G; Pilato E; Martin Suarez S; Montalto A; Lilla Della Monica P; Grigioni F; Frascaroli G; Menichetti A; Di Bartolomeo R; Arpesella G
    Artif Organs; 2014 Jul; 38(7):E129-41. PubMed ID: 24841637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Veno-Arterial Extracorporeal Membrane Oxygenation Support in Patients Undergoing Aortic Surgery.
    Zhong Z; Jiang C; Yang F; Hao X; Xing J; Wang H; Hou X
    Artif Organs; 2017 Dec; 41(12):1113-1120. PubMed ID: 28718889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VA-ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors.
    Fux T; Holm M; Corbascio M; Lund LH; van der Linden J
    Artif Organs; 2019 Feb; 43(2):132-141. PubMed ID: 30402887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry.
    Weiner L; Mazzeffi MA; Hines EQ; Gordon D; Herr DL; Kim HK
    Clin Toxicol (Phila); 2020 Jul; 58(7):705-710. PubMed ID: 31617764
    [No Abstract]   [Full Text] [Related]  

  • 12. Peripheral extracorporeal membrane oxygenation system as salvage treatment of patients with refractory cardiogenic shock: preliminary outcome evaluation.
    Loforte A; Montalto A; Ranocchi F; Della Monica PL; Casali G; Lappa A; Menichetti A; Contento C; Musumeci F
    Artif Organs; 2012 Mar; 36(3):E53-61. PubMed ID: 22352417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes in patients after extracorporeal membrane oxygenation support for post-cardiotomy cardiogenic shock: a single-centre experience of 92 cases.
    Guihaire J; Dang Van S; Rouze S; Rosier S; Roisne A; Langanay T; Corbineau H; Verhoye JP; Flécher E
    Interact Cardiovasc Thorac Surg; 2017 Sep; 25(3):363-369. PubMed ID: 28575211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation.
    Rigamonti F; Montecucco F; Boroli F; Rey F; Gencer B; Cikirikcioglu M; Reverdin S; Carbone F; Noble S; Roffi M; Banfi C; Giraud R
    Int J Cardiol; 2016 Oct; 221():741-5. PubMed ID: 27428314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical support with venoarterial extracorporeal membrane oxygenation (ECMO-VA): Short-term and long-term prognosis after a successful weaning.
    García-Gigorro R; Renes-Carreño E; Pérez-Vela JL; Marín-Mateos H; Gutiérrez J; Corrés-Peiretti MA; Delgado JF; Pérez-de la Sota E; Cortina-Romero JM; Montejo-González JC
    Med Intensiva; 2017 Dec; 41(9):513-522. PubMed ID: 28259366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Lactate Clearance on Early Outcomes in Pediatric ECMO Patients.
    Merkle-Storms J; Djordjevic I; Weber C; Avgeridou S; Krasivskyi I; Gaisendrees C; Mader N; Kuhn-Régnier F; Kröner A; Bennink G; Sabashnikov A; Trieschmann U; Wahlers T; Menzel C
    Medicina (Kaunas); 2021 Mar; 57(3):. PubMed ID: 33803807
    [No Abstract]   [Full Text] [Related]  

  • 17. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score.
    Schmidt M; Burrell A; Roberts L; Bailey M; Sheldrake J; Rycus PT; Hodgson C; Scheinkestel C; Cooper DJ; Thiagarajan RR; Brodie D; Pellegrino V; Pilcher D
    Eur Heart J; 2015 Sep; 36(33):2246-56. PubMed ID: 26033984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridge-to-recovery strategy using extracorporeal membrane oxygenation for critical pulmonary hypertension complicated with cardiogenic shock.
    Tsai MT; Hsu CH; Luo CY; Hu YN; Roan JN
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):55-61. PubMed ID: 25825011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central extracorporeal membrane oxygenation for refractory pediatric septic shock.
    MacLaren G; Butt W; Best D; Donath S
    Pediatr Crit Care Med; 2011 Mar; 12(2):133-6. PubMed ID: 20453704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Free Hemoglobin Is an Independent Predictor of Mortality among Patients on Extracorporeal Membrane Oxygenation Support.
    Omar HR; Mirsaeidi M; Socias S; Sprenker C; Caldeira C; Camporesi EM; Mangar D
    PLoS One; 2015; 10(4):e0124034. PubMed ID: 25902047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.